CDH1 and squamous cell carcinoma: Through meta-analysis of the prognostic significance of E-cadherin in several cancers, including squamous cell carcinoma, colorectal carcinoma, and ovarian cancer [28–30], it has been demonstrated that negative E-cadherin expression is associated with poorer prognosis in carcinoma.